Biology Atlas

Map / Assays

assay · intermediate · partly written

ChIP-seq

ChIP-seq finds where a chosen protein or histone mark sits on the genome by pulling the DNA bound to it out of fragmented chromatin with an antibody and sequencing it.

Also called: chromatin immunoprecipitation sequencing, ChIP

What it answers and what it cannot see

ChIP-seq maps where a chosen protein or mark is enriched, averaged over many cells. It cannot show that the signal is binding rather than assay artefact, that the site is functional, or what any one cell looks like. 123

Reported, not yet replicated

Known artefacts more

Hyper-ChIPable loci: in budding yeast, 238 euchromatic loci were enriched for three unrelated silencing proteins, sat in highly expressed regions, and a nuclear-localised GFP reproduced the enrichment in an expression-dependent way. The paper calls this a likely technical issue with the immunoprecipitations. Antibody quality is the other standing risk, which is why the ENCODE guidelines address antibody validation. The numbers about antibody cross-reactivity in vendor material were not opened here and are not stated. Crosslinking and total-chromatin solubilisation are the features that in situ methods were designed to avoid. 321

Reported, not yet replicated

Relation to the newer in situ assays more

CUT&RUN reports needing about one tenth of the sequencing depth of ChIP (the method authors' claim). The CUT&Tag authors report that about 2 million CUT&Tag reads matched the peak coverage of about 20 million ChIP-seq reads, again their own comparison. An independent benchmark of CUT&Tag used ENCODE ChIP-seq as its reference, which makes ChIP-seq the yardstick, with its own artefacts, for the newer assays. 145

Reported, not yet replicated

Antibodies differ between lots more

A test of anti-histone antibodies found broad ranges of affinity and specificity; two lots of one anti-H3K9me3 antibody had similarly low affinity but substantially different specificity profiles, and peptide-array and ChIP-format tests disagreed for most antibodies. Antibody validation therefore has to be done in the assay format and per lot. 6

Reported, not yet replicated

Question answered

Where, across a population of cells, a protein or histone modification is enriched on the genome. The answer is an enrichment of reads over background, not a count of bound molecules. 12

Established

Readout physical

Counts of sequenced DNA fragments that an antibody pulled down from fragmented, solubilised chromatin, piled up along the genome and turned into peaks by a statistical caller. A peak is a call on read counts, not an object in the cell. 12

Established

Not measured

It does not show that a factor is functionally acting at a peak, which cells carry the signal (it averages over the population), or how many molecules are bound. Enrichment can also come from the assay, not the biology: unrelated proteins were enriched at the same highly transcribed loci in yeast ("hyper-ChIPable" loci), and a nuclear GFP gave the same expression-dependent signal. 32

Reported, not yet replicated

Setting

Sample prep

Chromatin is fragmented and solubilised as a whole, and an antibody pulls down its target. The CUT&RUN paper contrasts this with in situ methods that avoid crosslinking and solubilisation problems. 1

Reported, not yet replicated

Conditions

The ENCODE consortia guidelines name the conditions that change the answer: antibody validation, experimental replication, sequencing depth, and how data quality is assessed. 2

Established

Still open here

Not yet written: Where in cascade, Throughput class, Throughput, Time per run, Cost, Engineerable variants, Use cases, Before after, Capital, Emerging, ML role, Data availability.

Linked from

Sources

  1. Skene, P.J., Henikoff, S.. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife (2017). paper; opened 2026-11-17 all records citing this
  2. Landt, S.G., Marinov, G.K., Kundaje, A., et al.. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Research (2012). paper; opened 2026-11-17 all records citing this
  3. Teytelman, L., Thurtle, D.M., Rine, J., van Oudenaarden, A.. Highly expressed loci are vulnerable to misleading ChIP localization of multiple unrelated proteins. PNAS (2013). paper; opened 2026-11-17 all records citing this
  4. Kaya-Okur, H.S., Wu, S.J., Codomo, C.A., et al.. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nature Communications (2019). paper; opened 2026-11-17 all records citing this
  5. Abbasova, L., Urbanaviciute, P., Hu, D., et al.. CUT&Tag recovers up to half of ENCODE ChIP-seq histone acetylation peaks. Nature Communications (2025). paper; opened 2026-11-17 all records citing this
  6. Nishikori S, Hattori T, Fuchs SM, et al.. Broad ranges of affinity and specificity of anti-histone antibodies revealed by a quantitative peptide immunoprecipitation assay. (2012). paper; opened 2026-11-17 all records citing this
Where it sits on the map
History of this record (3)

This record has been changed 3 times, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.

Status
partly written
Last updated
2026-11-17
Record
content/assays/chip-seq.json